View Older Stories View More Recent Stories

Mar 27, 2017 05:44PM Form 4 KalVista Pharmaceuticals For: Mar 23 Filed by: RA CAPITAL MANAGEMENT, LLC
Mar 8, 2017 08:30AM Spero Therapeutics Secures $51.7 Million in Oversubscribed Series C Financing
Mar 7, 2017 03:00AM Biohaven Closes Second Tranche Of Private Placement And Appoints Two New Directors To Board
Feb 16, 2017 04:05PM Form 13F-HR/A RA CAPITAL MANAGEMENT, For: Dec 31
Feb 16, 2017 04:03PM Form 13F-HR/A RA CAPITAL MANAGEMENT, For: Dec 31
Feb 15, 2017 09:11AM Form SC 13G/A Ascendis Pharma A/S Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 15, 2017 07:10AM Form SC 13G/A Strongbridge Biopharma Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 15, 2017 07:10AM Form SC 13G/A SANUWAVE Health, Inc. Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 15, 2017 07:10AM Form SC 13G/A Zynerba Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 15, 2017 07:10AM Form SC 13G/A ARDELYX, INC. Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 15, 2017 07:10AM Form SC 13G/A Protagonist Therapeutics Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 15, 2017 07:10AM Form SC 13G/A ACHILLION PHARMACEUTICAL Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 15, 2017 07:10AM Form SC 13G/A TENAX THERAPEUTICS, INC. Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 15, 2017 07:10AM Form SC 13G/A Regulus Therapeutics Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 15, 2017 07:09AM Form SC 13G/A TG THERAPEUTICS, INC. Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 15, 2017 07:09AM Form SC 13G/A PROTEON THERAPEUTICS Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 15, 2017 07:09AM Form SC 13G/A AQUINOX PHARMACEUTICALS, Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 15, 2017 07:09AM Form SC 13G/A Cidara Therapeutics, Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 15, 2017 07:08AM Form SC 13G/A Aclaris Therapeutics, Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 15, 2017 07:08AM Form SC 13G/A ZOGENIX, INC. Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 15, 2017 07:08AM Form SC 13G/A DERMA SCIENCES, INC. Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 14, 2017 06:12PM Form SC 13G/A Axovant Sciences Ltd. Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 14, 2017 05:57PM Form SC 13G/A ARCA biopharma, Inc. Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 14, 2017 05:51PM Form SC 13G/A AveXis, Inc. Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 14, 2017 05:49PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Dec 31
Feb 14, 2017 04:39PM Form SC 13D KalVista Pharmaceuticals Filed by: RA CAPITAL MANAGEMENT, LLC
Jan 9, 2017 09:05AM Ivantis Raises $25 Million Series C to Fund Future US Commercialization of the Hydrus(TM) Microstent for Minimally Invasive Glaucoma Surgery (MIGS)
Jan 6, 2017 09:15AM Kala Pharmaceuticals to Present Update on Phase 3 Programs at the 35th Annual J.P. Morgan Healthcare Conference
Jan 5, 2017 10:13AM Satsuma Pharmaceuticals Spins Out from Shin Nippon Biomedical Laboratories (SNBL) with Funding from Leading Institutional Life Science Investors
Dec 23, 2016 04:16PM Form SC 13G AveXis, Inc. Filed by: RA CAPITAL MANAGEMENT, LLC
Dec 6, 2016 06:03AM Form SC 13G/A Ascendis Pharma A/S Filed by: RA CAPITAL MANAGEMENT, LLC
Nov 28, 2016 08:00AM Synthorx Appoints Patrick J. Doyle as Chief Business Officer
Nov 23, 2016 07:24PM Form 4 KalVista Pharmaceuticals For: Nov 21 Filed by: RA CAPITAL MANAGEMENT, LLC
Nov 14, 2016 05:18PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Sep 30
Nov 9, 2016 04:32PM Form SC 13D Ra Pharmaceuticals, Inc. Filed by: RA CAPITAL MANAGEMENT, LLC
Nov 1, 2016 03:00AM Biohaven Secures $80 Million in Oversubscribed Private Financing to Advance Phase 3 Clinical Trials
Nov 1, 2016 03:00AM Biohaven Secures $80 Million in Oversubscribed Private Financing to Advance Phase 3 Clinical Trials
Oct 31, 2016 07:42PM Form 4 Ra Pharmaceuticals, Inc. For: Oct 31 Filed by: RA CAPITAL MANAGEMENT, LLC
Oct 26, 2016 02:04PM TiGenix publishes transparency notifications pursuant to Article 14 of the Law of May 2, 2007
Oct 26, 2016 02:00PM TiGenix publishes transparency notifications pursuant to Article 14 of the Law of May 2, 2007
Oct 21, 2016 04:32PM Form SC 13G/A ALCOBRA LTD. Filed by: RA CAPITAL MANAGEMENT, LLC
Oct 6, 2016 04:30PM Form SC 13G/A Aclaris Therapeutics, Filed by: RA CAPITAL MANAGEMENT, LLC
Sep 19, 2016 05:16PM Form 4 Aclaris Therapeutics, For: Sep 15 Filed by: RA CAPITAL MANAGEMENT, LLC
Sep 15, 2016 10:00AM The Economist Presents: "The War on Cancer: Scaling Progress"
Aug 25, 2016 04:16PM Form SC 13G Protagonist Therapeutics Filed by: RA CAPITAL MANAGEMENT, LLC
Aug 15, 2016 04:31PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Jun 30
Aug 15, 2016 04:30PM Form SC 13G Vitae Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, LLC
Aug 12, 2016 07:30AM Arrowhead Pharmaceuticals Closes $45 Million Private Offering
Aug 11, 2016 02:51AM KalVista Announces Initiation of a Phase 1 Clinical Trial of KVD818 for the Treatment of Hereditary Angioedema
Jul 28, 2016 04:33PM Form SC 13G ARDELYX, INC. Filed by: RA CAPITAL MANAGEMENT, LLC
View More Recent Stories View Older Stories